Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found a causal relationship between type 1 diabetes and autoimmune disorders such as SLE, RA, and MS in Europe, but not between T1DM and SLE in East Asia, highlighting the need for preventive monitoring in affected regions.

This position statement from the Androgen Excess-Polycystic Ovary Syndrome Society highlights the need to address the overlooked behavioral and psychosocial issues like depression, anxiety, and eating disorders in women with PCOS, emphasizing the lack of adequate evidence-based treatments for these challenges.

This study found that lower urinary tract symptoms in older men with benign prostatic hyperplasia negatively impact sexual function and mental health, suggesting the importance of early intervention to improve quality of life.

This study found that men with early-onset androgenetic alopecia may experience less benefit from rosuvastatin treatment in terms of improving cardiometabolic risk factors compared to men with normal hair growth.

This study suggests that continuing finasteride therapy after mastectomy does not significantly affect gynecomastia recurrence in men taking finasteride for alopecia.

This study found that Finnish men using 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had improved disease-specific survival compared to non-users, suggesting potential benefits of the treatment.

This study found that men aged 60 or older with postoperative urinary retention were more likely to undergo bladder outlet procedures within three years.

This review discusses the societal impact and treatment development for androgenetic alopecia, highlighting promising new drugs but reporting no new clinical results.

This article discusses the documented benefits of finasteride for managing benign prostatic hyperplasia, noting the need for monitoring due to its effects on serum PSA levels; it reports no adverse impact on prostate cancer detection.

This study introduced an innovative metric for assessing college students' mental health, incorporating temporal perception and a hybrid clustering algorithm, and found it achieved over 90% accuracy, outperforming existing methods in evaluating mental health during public health challenges.

This study found an association between sleep disturbances and androgenetic alopecia in men, with severe AGA linked to shorter sleep duration, poorer sleep quality, and higher STOP-BANG scores.

This study found that lichen planopilaris in men typically presents similarly to women, with a lower likelihood of nonscalp hair loss and a higher association with mucosal lichen planus and thyroid disease.

This article discusses cosmetic surgeries offered to men in the UK and highlights potential risks but reports no new findings.

In this study, ads in leading Indian men's magazines featured more international brands and Caucasian models, while promoting a class-based global masculinity among upper-class urban Indian men.

A gene mutation causes a rare hereditary hair loss, offering potential for new treatments.

This case report describes two transgender men using subdermal testosterone pellets for gender affirmation, finding they tolerated the treatment, but one returned to injections; firm conclusions on pellets' suitability require further study.

This report discusses the improved access to care and patient benefits of telemedicine for men with androgenetic alopecia, but it provides no new clinical results.

FFA in men shows unique features and treatment results vary widely.

This review discusses the impact of COVID-19 on lower urinary tract symptoms and benign prostatic enlargement, noting altered patient care and management, but provides no new clinical results.

This study found that in men, elevated androgen levels can occur at any age, with older men potentially exhibiting increased total testosterone due to higher levels of SHBG, and younger men showing various clinical manifestations like acne and alopecia.

This article discusses the approval status of 5α-reductase inhibitors for androgenetic alopecia, noting finasteride is FDA-approved for certain men while dutasteride is not approved in the US for this condition; it reports no new results.

This study found that men with androgenetic alopecia had higher serum levels of testosterone and DHT compared to controls, suggesting a significant role of serum androgens in AGA development and progression.

This article reviews melasma in men, its causes, and treatment options, but reports no new clinical findings.

This essay discusses the author's views on establishing a successful academic laboratory and reports no new research findings.

This study identified hypogonadism in 65% of men with Cushing syndrome, suggesting glucocorticoid excess may affect the hypothalamic-pituitary level or testosterone metabolism.

This article reviews the Clinical Pearls presentation format introduced at the American College of Physicians' 2001 meeting for its effectiveness in applying practical clinical tips, but provides no new empirical results.

Testosterone therapy may help men with osteoporosis.

This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.